Pfizer is on the Downside

Pfizer (PFE), one of the largest pharmaceutical companies, is on the price downside. Since PFE peaked on April 12, 1999 at $45.23, the stock has lost one-half of its value and is below a key support level of $24. Pfizer has a strong research and development program but its future earnings are uncertain. Avoid this stock.

Home | Making Money | Portfolios | Dividends | Retirement | Articles | Charts | Stocks | Tables